Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb 761 for chronic tinnitus (Poland, Phase 2)
2016-000315-32Phase 2Completed
- Sponsor
- Schwabe Group
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ginkgo biloba extract in tinnitus, sponsored by Schwabe Group. Primary endpoint: Effectiveness. Started Jul 2016; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2016-000315-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000315-32.